← Back to search

IDEAYA Biosciences Inc

IDYA · NASDAQ

Research and Development in Biotechnology

IDEAYA Biosciences Inc. is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies. IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality - which represents an emerging class of precision medicine targets.

ESG Scores

Overall ESG
7.1
Environmental
6.6
Social
3.9
Governance
6.3

Gender Diversity

Female Directors0.3333%
Women in Workforce0.43200000000000005%
CEO GenderMale

Market Data

Price$33.60-0.31 (-0.91%)
Market Cap$2.98B
P/E Ratio
EPS$—
52W High$39.28
52W Low$15.84
Beta0.06